TNF and arthritic joint disease: These data highlight the potential therapeutic advantage of an alternative therapeutic scheme involving the combination of a low dose anti-TNF treatment with small molecule kinase inhibitors with potential clinical benefits for the treatment of arthritis and related comorbidities.